This session was the first meeting of the new Health Research Alliance Clinical Trials Interest Group! Initially, this group is focusing on the benefits, challenges, and strategies for enhancing the... read more →
The first call of the newly formed AI and LLMs Learning Community was a discussion around policy development, implementation, and compliance, as well future events, including a possible breakout session... read more →
Health research is an international pursuit, with research being done across the world by scientists from every country. International scientists undoubtedly bring diverse perspectives to the health research field. However,... read more →
Diane Saunders led an HRA Analyzer Lunch & Learn session where she (re-)introduced HRA Analyzer, the grants database exclusively for HRA members, including: how to link and/or upload your organization’s... read more →
In this DEI Community Call, the DEI learning community co-chairs presented highlights from the recent NASEM report on Advancing Antiracism, Diversity, Equity, and Inclusion in STEMM Organizations. After the presentation,... read more →
The June open mic webinar Grants Administration Community was an open discussion starting with (1) international grantmaking/handling payments, (2) support for working parents—caregiving expenses, family leave considerations, and (3) handling... read more →
The Explore the Value of Open (EVO) Program hosted a webinar on the topics listed below: Reviewed expanded policy worksheet(Kristen Ratan added columns for OSTP Nelson member guidance, NIH Guidance... read more →
Empowering early career scientists and improving gender diversity of life sciences faculty at the highest levels What is Leading Edge? Leading Edge is an initiative to improve the gender diversity... read more →
The May open mic webinar Grants Administration Community was an open discussion starting with (1) handling awardee institution transfers, (2) awardee as a party to the grant agreement, and (3)... read more →
FDA RWD & RWE Draft Guidance Discussion In recent years, the U.S. Food and Drug Administration has released several draft guidance documents related to real-world data and evidence, including one... read more →